Amlodipine, an anti‐hypertensive drug, alleviates non‐alcoholic fatty liver disease by modulating gut microbiota
Y Li, D Zhao, M Qian, J Liu, C Pan… - British journal of …, 2022 - Wiley Online Library
Background and Purpose Non‐alcoholic fatty liver disease (NAFLD) represents a severe
public health problem. It often coexists with hypertension in the context of metabolic …
public health problem. It often coexists with hypertension in the context of metabolic …
Amlodipine, an anti-hypertensive drug, alleviates non-alcoholic fatty liver disease by modulating gut microbiota.
Y Li, D Zhao, M Qian, J Liu, C Pan, X Zhang… - British Journal of …, 2022 - europepmc.org
Background and purpose Non-alcoholic fatty liver disease (NAFLD) represents a severe
public health problem. It often coexists with hypertension in the context of metabolic …
public health problem. It often coexists with hypertension in the context of metabolic …
Amlodipine, an anti-hypertensive drug, alleviates non-alcoholic fatty liver disease by modulating gut microbiota
Y Li, D Zhao, M Qian, J Liu, C Pan… - British journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Background and purpose Non-alcoholic fatty liver disease (NAFLD) represents a severe
public health problem. It often coexists with hypertension in the context of metabolic …
public health problem. It often coexists with hypertension in the context of metabolic …
[PDF][PDF] Amlodipine, an anti-hypertensive drug, alleviates non-alcoholic fatty liver disease by modulating gut microbiota
Y Li, D Zhao, M Qian, J Liu, C Pan, X Zhang, X Duan… - 2021 - scholar.archive.org
Background and Purpose: Non-alcoholic fatty liver disease (NAFLD) represents a severe
public health problem. It often coexists with hypertension in the context of metabolic …
public health problem. It often coexists with hypertension in the context of metabolic …